Bioaffinity technologies reports record growth in cypath® lung test volume for third quarter 2025

San antonio--(business wire)-- #biaf--sales of bioaffinity's cypath® lung test for lung cancer reached a new high in q3 2025, representing a 95% increase over the previous quarter.

BIAF Ratings Summary

BIAF Quant Ranking